Expected next investor conference call information:
Conference Call Date: 11/16/2009
Conference Call Time (ET): 11:00 AM
Conference Call URL: http://phx.corporate-ir.net/playerlink.zhtml?c=107533&s=wm&e=2539678

StockProfiler.US is the Unquestioned Leader in Introducing Leading Microcap Companies! Sign up today at www.stockprofiler.us to receive our FREE newsletter and important updates in the market. Twitter and Facebook users can find us at StockProfilerUS. Contact us at 603-424-4420 to get your company the recognition it deserves!

**************************************************

PLEASE NOTE: All news in this release is summarized. To read the full news release, go to the Leader in Market News, www.stockprofiler.us, click the Headline Tab, enter the ticker symbol and click the news link.

**************************************************

Derma Sciences, Inc. closed at $0.61 Thursday, trading 4,250 shares.

Company News- November 6, 2009: Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call

Derma Sciences, Inc. (OTC Bulletin Board: DSCI) earlier today announced plans to release its third quarter 2009 results before market on Monday, November 16, 2009.

About Derma Sciences

Derma Sciences is a specialty medical device / pharmaceutical company focusing on advanced wound care. Its key product, MEDIHONEY , is sold throughout the world by Derma Sciences and Comvita New Zealand -- the licensor of the patented honey-based technology -- and is the leading brand of honey-based dressings for the management of wounds and burns. For more information about Derma Sciences, Inc., visit http://www.dermasciences.com.

**************************************************

Valley Forge Composite Technologies, Inc. closed at $0.50 Thursday, trading 33,550 shares.

Company News- November 6, 2009: Valley Forge Composite Technologies, Inc. Division Receives an Additional Order of $2,700,000 for Momentum Wheel Products

Valley Forge Composite Technologies, Inc. (OTC Bulletin Board: VLYF) earlier today reported an additional order of $2,700,000 for its momentum wheel line of products.

About Valley Forge Composite Technologies, Inc.

Valley Forge Composite Technologies, Inc. develops, manufactures and distributes next-generation detection systems. Its THOR LVX system is designed to detect nuclear material, explosives and contraband hidden in cargo containers and baggage, even through shielding. VLYF is also marketing the Odin personal screening system for use in airports, high-security buildings and border entry points. More information about Valley Forge Composite Technologies, Inc. can be found at www.vlyf.com.

**************************************************

Proginet Corporation closed at $0.00 Thursday, trading 0 shares.

Company News- November 6, 2009: Proginet Announces Preliminary First Quarter 2010 Financial Results

Proginet Corporation (OTCBB: PRGF) earlier today announced preliminary (unaudited) financial results for the fiscal 2010 first quarter ended October 31, 2009.

About Proginet Corporation

Proginet Corporation offers a universal, multi-platform software solution for fast, inexpensive and secure file transfers both inside and outside the enterprise. Proginet's CyberFusion Integration Suite (CFI) is used by companies of all sizes to conduct business more efficiently while protecting customer data and limiting the risks associated with sharing proprietary information with partners and colleagues around the globe. With over 20 years of experience in the managed file transfer arena, Proginet's global customer base spans more than 30 countries and includes many Fortune 500 companies. Headquartered in New York, the company is publicly traded on the OTCBB under the symbol [PRGF.OB]. For more information, visit www.proginet.com.

**************************************************

The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Stock Profiler.US, LLC's News Division includes but is not limited to: www.stockprofiler.us; www.associatesfortune.com; www.fastmoneytalk.com; www.markettelegraph.com; www.thewallstreetleader.com; and www.daytradersdigest.com. Stock Profiler.US, LLC has been compensated for services rendered; Stock Profiler.US, LLC is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter.

Please consult a broker before purchasing or selling any securities mentioned herein. To view full disclaimers and terms of use, go to www.stockprofiler.us.

Keywords: Small Cap Investments, Investor Relations, I/R Services, Investment Tools, Stock Profiles, Stock Market Quotes, Media Coverage, Google Finance, Google Analytics, Google, Yahoo Finance, Yahoo, MSNBC, Search Engine, AOL Finance, AOL, Businesswire, PR Newswire Alphatrade, Comtex, Comtex A, Comtex B, Zacks, Real Trader, Market News Publications, AFX U.K., Future World, JAGNotes.com, Internetwire, EURO PR News, First Call, PrimeZone, U.S. News, Forbes, Track Notes

CONTACT: Stock Profiler.US e-mail: info@stockprofiler.us WWW: http://www.stockprofiler.us

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

Expected next investor conference call information:
Conference Call Date: 11/16/2009
Conference Call Time (ET): 11:00 AM
Conference Call URL: http://phx.corporate-ir.net/playerlink.zhtml?c=107533&s=wm&e=2539678

For those who are unavailable to listen to the live broadcast, a replay will be available through December 16, 2009 and can be accessed by dialing 888-286-8010 (domestic), and 617-801-6888 (international). The passcode is 43541503.

About Derma Sciences

Derma Sciences is a specialty medical device / pharmaceutical company focusing on advanced wound care. Its key product, MEDIHONEY(R), is sold throughout the world by Derma Sciences and Comvita New Zealand -- the licensor of the patented honey-based technology -- and is the leading brand of honey-based dressings for the management of wounds and burns. The product has been shown to be effective in a variety of wounds and burns, and was the focus of a positive large-scale randomized controlled trial on leg ulcers. Derma's recently FDA cleared BIOGUARD(TM) Barrier Dressing is the Company's latest new product entrant into the $14 billion global wound care market. The barrier technology was licensed from Quick-Med Technologies, Inc. in Q1 of 2007. Derma also has in development DSC127, a novel angiotensin analog for accelerated wound healing and scar reduction. DSC127 was licensed from the University of Southern California in Q4 of 2007. Patient enrollment for a Phase II study began in Q4 of 2008. Results from this study are expected to be submitted to the FDA in Q2 of 2010.

For more information about Derma Sciences, Inc., visit http://www.dermasciences.com.

    Contact:

        Derma Sciences, Inc.
        Edward J. Quilty
        Chairman and CEO
        equilty@dermasciences.com
        (609) 514-4744

        The Investor Relations Group
        212-825-3210
        Investor Relations:
        Jason Strominger
        Or
        Media Relations:
        Susan Morgenbesser

SOURCE Derma Sciences, Inc.

http://www.dermasciences.com